for healthier lives
The #UMPrecisionHealth User Story Series debuts with @UMichPharmacy Assistant Prof. Dan Hertz. He explains how the Michigan Genomics Initiative facilitates his research identifying cancer treatment biomarkers and toxicity.
A $1.4 million grant from the National Institutes of Health Community Engagement Alliance (CEAL) Against COVID-19 Disparities supports work to promote COVID-19 research and inclusivity among African Americans and Hispanic/Latino populations. Communities Conquering COVID, or C3, was launched by Michigan Medicine, MICHR, and the University of Michigan School of Public Health.
Precision Health member Arul Chinnaiyan was senior author of a study in JAMA Oncology showing the benefits of next-generation tumor sequencing for patients with advanced cancer or cancer of unknown origin. The study examined nearly seven years’ worth of data from 1,015 patients who participated in the Michigan Oncology Sequencing Program (Mi-ONCOSEQ).
From collaboration to validation: How a team of engineers, clinicians, programmers, and administrators evaluated one of the most widely implemented predictive models
A team of U-M researchers convened to study how well the Epic Deterioration Index actually worked in predicting which COVID patients were at highest risk for deteriorating and requiring ICU-level care, and which were at the lowest risk.
Precision health in the palm of your hand
Associate professor Reetuparna Das and professor Satish Narayanasamy, along with professor David Blaauw, are leading a team funded by the National Science Foundation and the Kahn Foundation that is developing a hardware/software platform to accelerate next-generation genomic sequencing.
RFA: Precision Health 2021 Investigators Awards
The Investigators Awards program anticipates funding up to eight two-year awards in 2021 to support the development of precision health science, tools, and datasets. Funding available per project may total up to $200,000.